These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15289816)

  • 21. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
    Tiwari AK; Zai CC; Likhodi O; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Müller DJ; Kennedy JL
    Pharmacogenomics J; 2012 Jun; 12(3):260-6. PubMed ID: 21266946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations.
    Nakajima T; Jorde LB; Ishigami T; Umemura S; Emi M; Lalouel JM; Inoue I
    Am J Hum Genet; 2002 Jan; 70(1):108-23. PubMed ID: 11731937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common functional promoter variant links CNR1 gene expression to HDL cholesterol level.
    Feng Q; Vickers KC; Anderson MP; Levin MG; Chen W; Harrison DG; Wilke RA
    Nat Commun; 2013; 4():1973. PubMed ID: 23748922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
    Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
    Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.
    Flanagan JM; Gerber AL; Cadet JL; Beutler E; Sipe JC
    Hum Genet; 2006 Nov; 120(4):581-8. PubMed ID: 16972078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
    Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
    Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.
    Evans DE; Sutton SK; Jentink KG; Lin HY; Park JY; Drobes DJ
    Genes Brain Behav; 2016 Sep; 15(7):621-6. PubMed ID: 27453054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of PTPRB gene polymorphism with drug addiction.
    Ishiguro H; Gong JP; Hall FS; Arinami T; Uhl GR
    Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1167-72. PubMed ID: 18361428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study.
    Park JM; Choi MG; Cho YK; Lee IS; Kim SW; Choi KY; Chung IS
    J Clin Gastroenterol; 2011 Jan; 45(1):45-9. PubMed ID: 20505532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease.
    Liu QR; Walther D; Drgon T; Polesskaya O; Lesnick TG; Strain KJ; de Andrade M; Bower JH; Maraganore DM; Uhl GR
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):93-103. PubMed ID: 15666411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.
    Bidwell LC; Metrik J; McGeary J; Palmer RH; Francazio S; Knopik VS
    J Stud Alcohol Drugs; 2013 Nov; 74(6):867-78. PubMed ID: 24172113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The promoter region of the MDR1 gene is largely invariant, but different single nucleotide polymorphism haplotypes affect MDR1 promoter activity differently in different cell lines.
    Wang B; Ngoi S; Wang J; Chong SS; Lee CG
    Mol Pharmacol; 2006 Jul; 70(1):267-76. PubMed ID: 16608921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DRD2 allele frequencies and linkage disequilibria, including the -141CIns/Del promoter polymorphism, in European-American, African-American, and Japanese subjects.
    Gelernter J; Kranzler H; Cubells JF; Ichinose H; Nagatsu T
    Genomics; 1998 Jul; 51(1):21-6. PubMed ID: 9693029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients.
    Núñez M; Perdomo S; Moreta J; Santos-Briz Á; González-Sarmiento R
    Clin Transl Oncol; 2010 Dec; 12(12):825-8. PubMed ID: 21156413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in CNR1 locus influences protein intake and smoking status in the Central-European population.
    Bienertova-Vasku J; Bienert P; Slovackova L; Sablikova L; Piskackova Z; Forejt M; Splichal Z; Zlamal F; Vasku A
    Nutr Neurosci; 2012 Jul; 15(4):163-70. PubMed ID: 22334331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of CB1 cannabinoid receptor (CNR1) gene polymorphisms with risk for alcohol dependence: Evidence from meta-analyses of genetic and genome-wide association studies.
    Pabalan N; Chaweeborisuit P; Tharabenjasin P; Tasanarong A; Jarjanazi H; Eiamsitrakoon T; Tapanadechopone P
    Medicine (Baltimore); 2021 Oct; 100(43):e27343. PubMed ID: 34713823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD80 and CD86 polymorphisms in populations of various ancestries: 5 new CD80 promoter alleles.
    Beltrame MH; Pincerati MR; Dalla-Costa R; Wassem R; Köhler KF; Chautard-Freire-Maia EA; Tsuneto LT; Petzl-Erler ML
    Hum Immunol; 2012 Jan; 73(1):111-7. PubMed ID: 22074996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
    Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
    Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comments on "Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans".
    Köpke K
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):64. PubMed ID: 15389767
    [No Abstract]   [Full Text] [Related]  

  • 40. Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling.
    Chiang YC; Lo YN; Chen JC
    J Neurochem; 2013 Oct; 127(2):163-76. PubMed ID: 23952963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.